HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

I Stamenkovic Selected Research

keratinocyte CD44

12/2000Decrease in epidermal CD44 expression as a potential mechanism for abnormal hyaluronate accumulation in superficial dermis in lichen sclerosus et atrophicus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


I Stamenkovic Research Topics

Disease

6Neoplasms (Cancer)
02/2007 - 01/2000
3Carcinoma (Carcinomatosis)
02/2001 - 06/2000
2Sarcoma (Soft Tissue Sarcoma)
10/2007 - 09/2007
2Neoplasm Metastasis (Metastasis)
02/2001 - 12/2000
1Genetic Translocation (Chromosomal Translocation)
10/2007
1Acute Kidney Injury (Acute Renal Failure)
08/2007
1Nervous System Neoplasms (Neoplasms, Nervous System)
02/2007
1Neurilemmoma (Schwannoma)
02/2007
1Neurofibromatosis 2 (Neurofibromatosis Type II)
02/2007
1Carcinogenesis
02/2007
1Fasciitis (Fascitis)
03/2006
1Aggressive Fibromatosis (Desmoid)
03/2006
1Inflammation (Inflammations)
03/2006
1Necrosis
03/2006
1Lewis Lung Carcinoma
02/2001
1Circulating Neoplastic Cells
12/2000
1Mucinoses
12/2000
1Lichen Sclerosus et Atrophicus (Lichen Sclerosus)
12/2000
1Infections
10/2000
1Medullary Carcinoma
08/2000
1Papillary Carcinoma
08/2000
1Thyroid Neoplasms (Thyroid Cancer)
08/2000
1Ascites
06/2000

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
09/2007 - 12/2000
4Hyaluronic Acid (Hyaluronan)IBA
08/2007 - 06/2000
2Phosphotransferases (Kinase)IBA
10/2007 - 03/2006
2LigandsIBA
08/2007 - 08/2000
2Transforming Growth Factor beta (TGF-beta)IBA
03/2006 - 01/2000
2Matrix Metalloproteinases (MMPs)IBA
01/2001 - 12/2000
2CytokinesIBA
12/2000 - 01/2000
2Hyaluronan ReceptorsIBA
06/2000 - 01/2000
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
10/2007
1tyrosine receptor (receptor, tyrosine)IBA
10/2007
1Glycerol (Glycerine)FDA LinkGeneric
08/2007
1Amino AcidsFDA Link
02/2007
1Neurofibromin 2 (Merlin)IBA
02/2007
1radixinIBA
02/2007
1moesinIBA
02/2007
1Cell Surface ReceptorsIBA
02/2007
1ezrinIBA
02/2007
1Transcription Factors (Transcription Factor)IBA
03/2006
1CathepsinsIBA
03/2006
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
03/2006
1InterferonsIBA
03/2006
1Tyrosine (L-Tyrosine)FDA Link
03/2006
1Metalloproteases (Metalloproteinases)IBA
03/2006
1Plasminogen Activators (Plasminogen Activator)IBA
03/2006
1AngiopoietinsIBA
02/2001
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2001
1Angiopoietin-1IBA
02/2001
1Angiopoietin-2IBA
02/2001
1Complementary DNA (cDNA)IBA
01/2001
1Fas Ligand Protein (Fas Ligand)IBA
01/2001
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2001
1Pharmaceutical PreparationsIBA
01/2001
1Alcian BlueIBA
12/2000
1adhesion receptorIBA
12/2000
1GlobulinsIBA
12/2000
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2000
1Messenger RNA (mRNA)IBA
12/2000
1Matrix Metalloproteinase InhibitorsIBA
12/2000
1keratinocyte CD44IBA
12/2000
1Capsules (Microcapsules)IBA
10/2000
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2000
1Indicators and Reagents (Reagents)IBA
08/2000
1Caspase 10IBA
08/2000
1CaspasesIBA
08/2000
1Cycloheximide (Cicloheximide)IBA
08/2000
1Caspase 8 (Caspase-8)IBA
08/2000
1Protein Synthesis InhibitorsIBA
08/2000
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
01/2000

Therapy/Procedure

1Radiotherapy
09/2007
1Drug Therapy (Chemotherapy)
01/2001